Publication | Closed Access

Extreme Urinary Betaine Losses in Type 2 Diabetes Combined with Bezafibrate Treatment are Associated with Losses of Dimethylglycine and Choline but not with Increased Losses of Other Osmolytes

ObesityMetabolic SyndromeBezafibrate TreatmentUrologyBody CompositionPhysiologyDiabetesType 2Diabetic Kidney DiseaseDiabetes MellitusOther OsmolytesEndocrinologyMedicineHealth Sciences